Vivek Subbiah, MD

Chief of Early Phase Drug Development · Sarah Cannon Research Institute

OncologyNorth AmericaEstablished

Why follow Vivek

Shares real-time updates and authoritative analysis on early-phase clinical trials, precision medicine, genomics, and next-generation targeted therapies in oncology.

Writes about

Precision OncologyClinical TrialsDrug Development

Best for

Precision oncology researchers and clinical trialists.